Our mission of providing affordable medicines across many therapeutic areas globally is duly supported by the relentless efforts of our team of over 300 dedicated and talented scientists.

To maintain the gold standard in our innovations, we house state-of-the-art research facilities for our API process development at three locations in India, with dedicated teams working on synthetic, organic chemistry, process engineering and analytical development at multiple locations.

Our API pipeline consists of 75+ complex developments in the therapy areas of Oncology, Hep C, ARV, Diabetology, CVS, CNS, Respiratory etc.

Technologies such as process analytical technology, continuous flow reactors for process development among others are used in the API development process.

Using the principles of quality by design, incorporating design of experiments (DOE), we consistently develop robust and cost-effective processes.

API R&D has dedicated oncology and polypeptide development labs.

Our API Integrated Product Development (IPD) team has rolled out a programme for adopting principles of Green Chemistry with a vision for developing processes that are environment friendly. They make use of enzymatic transformations, reducing waste generation and recycling of suitable inputs.

We have highly experienced analytical research development team houses instrumentation such as NMR, LC-MS-MS, GC-MS, PXRD, single crystal XRD etc.

Our capabilities are limitless-from development of a simple achiral molecule to highly complex multi chiral centres molecule with a distinction of affordability and highest quality.